Drug Shortage Report for PROLEUKIN
| Report ID | 257813 |
| Drug Identification Number | 02130181 |
| Brand name | PROLEUKIN |
| Common or Proper name | Aldesleukin |
| Company Name | IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALDESLEUKIN |
| Strength(s) | 22000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 |
| ATC code | L03AC |
| ATC description | IMMUNOSTIMULANTS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2025-11-25 |
| Estimated end date | 2026-01-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-02 |
| Company comments | asdf |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 300 ROUSE BLVD. PHILADELPHIA, PENNSYLVANIA UNITED STATES 19112 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-02 | French | Compare |
| v1 | 2025-12-02 | English | Compare |
Showing 1 to 2 of 2